Medpace Holdings Total Liabilities 2014-2024 | MEDP

Medpace Holdings total liabilities from 2014 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Medpace Holdings total liabilities for the quarter ending September 30, 2024 were $1.203B, a 18.39% increase year-over-year.
  • Medpace Holdings total liabilities for 2023 were $1.098B, a 13.64% increase from 2022.
  • Medpace Holdings total liabilities for 2022 were $0.966B, a 36.65% increase from 2021.
  • Medpace Holdings total liabilities for 2021 were $0.707B, a 20.88% increase from 2020.
Medpace Holdings Annual Total Liabilities
(Millions of US $)
2023 $1,098
2022 $966
2021 $707
2020 $585
2019 $417
2018 $378
2017 $447
2016 $368
2015 $571
2014 $695
2013 $0
Medpace Holdings Quarterly Total Liabilities
(Millions of US $)
2024-09-30 $1,203
2024-06-30 $1,156
2024-03-31 $1,124
2023-12-31 $1,098
2023-09-30 $1,016
2023-06-30 $1,016
2023-03-31 $1,048
2022-12-31 $966
2022-09-30 $979
2022-06-30 $1,032
2022-03-31 $739
2021-12-31 $707
2021-09-30 $679
2021-06-30 $618
2021-03-31 $592
2020-12-31 $585
2020-09-30 $505
2020-06-30 $484
2020-03-31 $420
2019-12-31 $417
2019-09-30 $380
2019-06-30 $359
2019-03-31 $385
2018-12-31 $378
2018-09-30 $388
2018-06-30 $428
2018-03-31 $462
2017-12-31 $447
2017-09-30 $399
2017-06-30 $356
2017-03-31 $345
2016-12-31 $368
2016-09-30 $366
2016-06-30 $0
2016-03-31 $0
2015-12-31
2015-09-30 $0
2014-12-31 $695
2013-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Services $10.498B $1.886B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $93.361B 11.58
Cencora (COR) United States $48.280B 17.81
DiDi Global (DIDIY) China $22.212B 0.00
Natera (NTRA) United States $22.082B 0.00
ICON (ICLR) Ireland $17.675B 15.74
Viatris (VTRS) United States $15.958B 4.92
Avantor (AVTR) United States $14.143B 21.20
Revvity (RVTY) United States $13.634B 23.68
CochLear (CHEOY) Australia $12.777B 0.00
Solventum (SOLV) United States $12.233B 0.00
BioMerieux (BMXMF) France $11.895B 0.00
Charles River Laboratories (CRL) United States $10.011B 19.34
HealthEquity (HQY) United States $9.104B 49.41
Doximity (DOCS) United States $8.999B 52.97
Sonic Healthcare (SKHHY) Australia $8.862B 0.00
Bausch + Lomb (BLCO) Canada $6.892B 32.08
Life Times (LTH) United States $5.081B 33.63
Organon (OGN) United States $3.935B 3.97
Sotera Health (SHC) United States $3.631B 19.42
BrightSpring Health Services (BTSG) United States $3.265B 69.44
Surgery Partners (SGRY) United States $2.925B 33.35
Concentras Parent (CON) United States $2.789B 0.00
PACS (PACS) United States $2.515B 0.00
Alignment Healthcare (ALHC) United States $2.310B 0.00
Ardent Health Partners (ARDT) United States $2.259B 0.00
Premier (PINC) United States $2.195B 11.42
GeneDx Holdings (WGS) United States $2.162B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.995B 0.00
GoodRx Holdings (GDRX) United States $1.868B 49.00
Teladoc Health (TDOC) United States $1.828B 0.00
Progyny (PGNY) United States $1.315B 26.62
Pediatrix Medical (MD) United States $1.285B 12.57
CareDx (CDNA) United States $1.241B 0.00
Establishment Labs Holdings (ESTA) $1.206B 0.00
AMN Healthcare Services Inc (AMN) United States $0.984B 6.66
Embecta (EMBC) United States $0.797B 5.32
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.779B 0.00
SBC Medicals (SBC) United States $0.674B 0.00
InnovAge Holding (INNV) United States $0.662B 0.00
Auna S.A (AUNA) Luxembourg $0.522B 0.00
Sonida Senior Living (SNDA) United States $0.474B 0.00
DocGo (DCGO) United States $0.434B 16.35
Enhabit (EHAB) United States $0.380B 32.87
COMPASS Pathways (CMPS) United Kingdom $0.302B 0.00
ModivCare (MODV) United States $0.254B 13.79
LifeMD (LFMD) United States $0.251B 0.00
Sera Prognostics (SERA) United States $0.221B 0.00
Biodesix (BDSX) United States $0.186B 0.00
Nutex Health (NUTX) United States $0.179B 0.00
Beauty Health (SKIN) United States $0.176B 0.00
MultiPlan (MPLN) United States $0.112B 0.00
So-Young (SY) China $0.086B 16.60
Ascend Wellness Holdings (AAWH) United States $0.085B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.046B 0.00
NeueHealth (NEUE) United States $0.041B 1.10
IceCure Medical (ICCM) Israel $0.032B 0.00
Co-Diagnostics (CODX) United States $0.032B 0.00
Pheton Holdings (PTHL) China $0.031B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.021B 0.00
Oncology Institute (TOI) United States $0.012B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
KindlyMD (KDLY) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00